GoldenGolden
Advanced Search
Pherecydes Pharma

Pherecydes Pharma

A biotechnology company developing phage therapies for treating bacterial infections.

Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.

Funding
Series A

On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.

Series B

On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.

Timeline

January 15, 2018
Pherecydes Pharma raises a $10,600,000 series B round.
2006
Pherecydes Pharma was founded by Jerome Gabard and Manuel GEA.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Biotech raises funds to help produce phage therapies for bacterial infections

epmmagazine

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Anthony King
June 28, 2021
phys.org
Antibiotic resistant bacteria are killing more people each year, but scientists are turning to their natural virus predators to treat infections, as well as new vaccines to prevent disease.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.